共 61 条
[11]
Junghans R.P., Anderson C.L., The protection receptor for IgG catabolism is the beta2-microglobulin- containing neonatal intestinal transport receptor, Proc Natl Acad Sci USA, 93, pp. 5512-5516, (1996)
[12]
Dall Acqua W.F., Woods R.M., Ward E.S., Palaszynski S.R., Patel N.K., Brewah Y.A., Wu H., Kiener P.A., Langermann S., Increasing the affinity of a human IgG1 for the neonatal Fc receptor: Biological consequences, J Immunol, 169, pp. 5171-5180, (2002)
[13]
Ghetie V., Popov S., Borvak J., Radu C., Matesoi D., Medesan C., Ober R.J., Ward E.S., Increasing the serum persistence of an IgG fragment by random mutagenesis, Nat Biotechnol, 15, pp. 637-640, (1997)
[14]
Borvak J., Richardson J., Medesan C., Antohe F., Radu C., Simionescu M., Ghetie V., Ward E.S., Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice, Int Immunol, 10, pp. 1289-1298, (1998)
[15]
Ghetie V., Ward E.S., FcRn: The MHC class I-related receptor that is more than an IgG transporter, Immunol Today, 18, pp. 592-598, (1997)
[16]
Israel E.J., Taylor S., Wu Z., Mizoguchi E., Blumberg R.S., Bhan A., Simister N.E., Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells, Immunology, 92, pp. 69-74, (1997)
[17]
Baxter L.T., Zhu H., MacKensen D.G., Jain R.K., Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice, Cancer Res, 54, pp. 1517-1528, (1994)
[18]
Dickinson B.L., Badizadegan K., Wu Z., Ahouse J.C., Zhu X., Simister N.E., Blumberg R.S., Lencer W.I., Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line, J Clin Invest, 104, pp. 903-911, (1999)
[19]
Lobo E.D., Hansen R.J., Balthasar J.P., Antibody pharmacokinetics and pharmacodynamics, J Pharm Sci, 93, pp. 2645-2668, (2004)
[20]
Tang L., Persky A.M., Hochhaus G., Meibohm B., Pharmacokinetic aspects of biotechnology products, J Pharm Sci, 93, pp. 2184-2204, (2004)